Report Detail
Global Oncology Immunotherapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4350353 |
- 01 November, 2021 |
- Global |
- 103 Pages |
- QYResearch |
- Pharma & Healthcare
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
Market Insights
QY Research has lately published a report titled “Global Oncology Immunotherapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application”, with the help of industry-leading research methods, along with observing subtle details and understanding the overall dynamics.
The insights included in this report have been prepared in view of varied aspects that affect the growth. The report elucidates key drivers, trends, prospects, restraining factors, and challenges that players may across in the coming years. With the assistance of this research, players can recognize and capitalize on profitable opportunities. They can further utilize it to make the required advancements in their operations to acquire a competitive advantage over other participants.
The global Oncology Immunotherapy market size is projected to reach US$ million by 2027, from US$ million in 2020, at a CAGR of % during 2021-2027.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2016-2027. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Other
Segment by Application
Hospitals
Drugstores
Others
Regional Scope
This segment of the report offers a thorough regional study of the global Oncology Immunotherapy market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2016-2027. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2016-2021. Following is the list of key manufacturers observed in this research study:
Bristol-Myers Squibb
Merck & Co
Roche AG
AstraZeneca
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
Frequently Asked Questions
Which application segment captured the leading share in the Oncology Immunotherapy market?
How fragmented is the Oncology Immunotherapy market?
Which are the key growth drivers in the Oncology Immunotherapy market?
Which are the top strategies undertaken by the Oncology Immunotherapy market players?
Which technological trends are likely to affect the Oncology Immunotherapy market?
What is the expected Oncology Immunotherapy market size by 2027?
Which companies are dominating the Oncology Immunotherapy market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the Oncology Immunotherapy market growth?
Which are the emerging companies in the Oncology Immunotherapy market?
Table of Contents
1 Market Overview of Oncology Immunotherapy
- 1.1 Oncology Immunotherapy Market Overview
- 1.1.1 Oncology Immunotherapy Product Scope
- 1.1.2 Oncology Immunotherapy Market Status and Outlook
- 1.2 Global Oncology Immunotherapy Market Size Overview by Region 2016 VS 2021 VS 2027
- 1.3 Global Oncology Immunotherapy Market Size by Region (2016-2027)
- 1.4 Global Oncology Immunotherapy Historic Market Size by Region (2016-2021)
- 1.5 Global Oncology Immunotherapy Market Size Forecast by Region (2022-2027)
- 1.6 Key Regions, Oncology Immunotherapy Market Size (2016-2027)
- 1.6.1 North America Oncology Immunotherapy Market Size (2016-2027)
- 1.6.2 Europe Oncology Immunotherapy Market Size (2016-2027)
- 1.6.3 Asia-Pacific Oncology Immunotherapy Market Size (2016-2027)
- 1.6.4 Latin America Oncology Immunotherapy Market Size (2016-2027)
- 1.6.5 Middle East & Africa Oncology Immunotherapy Market Size (2016-2027)
2 Oncology Immunotherapy Market Overview by Type
- 2.1 Global Oncology Immunotherapy Market Size by Type: 2016 VS 2021 VS 2027
- 2.2 Global Oncology Immunotherapy Historic Market Size by Type (2016-2021)
- 2.3 Global Oncology Immunotherapy Forecasted Market Size by Type (2022-2027)
- 2.4 Immune Checkpoint Inhibitors
- 2.5 Cytokine-Based Immunotherapy
- 2.6 Cancer Vaccines
- 2.7 CAR-T Cell Therapy
- 2.8 Other
3 Oncology Immunotherapy Market Overview by Application
- 3.1 Global Oncology Immunotherapy Market Size by Application: 2016 VS 2021 VS 2027
- 3.2 Global Oncology Immunotherapy Historic Market Size by Application (2016-2021)
- 3.3 Global Oncology Immunotherapy Forecasted Market Size by Application (2022-2027)
- 3.4 Hospitals
- 3.5 Drugstores
- 3.6 Others
4 Oncology Immunotherapy Competition Analysis by Players
- 4.1 Global Oncology Immunotherapy Market Size by Players (2016-2021)
- 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology Immunotherapy as of 2020)
- 4.3 Date of Key Players Enter into Oncology Immunotherapy Market
- 4.4 Global Top Players Oncology Immunotherapy Headquarters and Area Served
- 4.5 Key Players Oncology Immunotherapy Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 Oncology Immunotherapy Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 Bristol-Myers Squibb
- 5.1.1 Bristol-Myers Squibb Profile
- 5.1.2 Bristol-Myers Squibb Main Business
- 5.1.3 Bristol-Myers Squibb Oncology Immunotherapy Products, Services and Solutions
- 5.1.4 Bristol-Myers Squibb Oncology Immunotherapy Revenue (US$ Million) & (2016-2021)
- 5.1.5 Bristol-Myers Squibb Recent Developments
- 5.2 Merck & Co
- 5.2.1 Merck & Co Profile
- 5.2.2 Merck & Co Main Business
- 5.2.3 Merck & Co Oncology Immunotherapy Products, Services and Solutions
- 5.2.4 Merck & Co Oncology Immunotherapy Revenue (US$ Million) & (2016-2021)
- 5.2.5 Merck & Co Recent Developments
- 5.3 Roche AG
- 5.3.1 Roche AG Profile
- 5.3.2 Roche AG Main Business
- 5.3.3 Roche AG Oncology Immunotherapy Products, Services and Solutions
- 5.3.4 Roche AG Oncology Immunotherapy Revenue (US$ Million) & (2016-2021)
- 5.3.5 AstraZeneca Recent Developments
- 5.4 AstraZeneca
- 5.4.1 AstraZeneca Profile
- 5.4.2 AstraZeneca Main Business
- 5.4.3 AstraZeneca Oncology Immunotherapy Products, Services and Solutions
- 5.4.4 AstraZeneca Oncology Immunotherapy Revenue (US$ Million) & (2016-2021)
- 5.4.5 AstraZeneca Recent Developments
- 5.5 Sanofi S.A.
- 5.5.1 Sanofi S.A. Profile
- 5.5.2 Sanofi S.A. Main Business
- 5.5.3 Sanofi S.A. Oncology Immunotherapy Products, Services and Solutions
- 5.5.4 Sanofi S.A. Oncology Immunotherapy Revenue (US$ Million) & (2016-2021)
- 5.5.5 Sanofi S.A. Recent Developments
- 5.6 Dendreon Pharmaceuticals
- 5.6.1 Dendreon Pharmaceuticals Profile
- 5.6.2 Dendreon Pharmaceuticals Main Business
- 5.6.3 Dendreon Pharmaceuticals Oncology Immunotherapy Products, Services and Solutions
- 5.6.4 Dendreon Pharmaceuticals Oncology Immunotherapy Revenue (US$ Million) & (2016-2021)
- 5.6.5 Dendreon Pharmaceuticals Recent Developments
- 5.7 Novartis
- 5.7.1 Novartis Profile
- 5.7.2 Novartis Main Business
- 5.7.3 Novartis Oncology Immunotherapy Products, Services and Solutions
- 5.7.4 Novartis Oncology Immunotherapy Revenue (US$ Million) & (2016-2021)
- 5.7.5 Novartis Recent Developments
- 5.8 Gilead Sciences Inc.
- 5.8.1 Gilead Sciences Inc. Profile
- 5.8.2 Gilead Sciences Inc. Main Business
- 5.8.3 Gilead Sciences Inc. Oncology Immunotherapy Products, Services and Solutions
- 5.8.4 Gilead Sciences Inc. Oncology Immunotherapy Revenue (US$ Million) & (2016-2021)
- 5.8.5 Gilead Sciences Inc. Recent Developments
- 5.9 Merck KGaA
- 5.9.1 Merck KGaA Profile
- 5.9.2 Merck KGaA Main Business
- 5.9.3 Merck KGaA Oncology Immunotherapy Products, Services and Solutions
- 5.9.4 Merck KGaA Oncology Immunotherapy Revenue (US$ Million) & (2016-2021)
- 5.9.5 Merck KGaA Recent Developments
6 North America
- 6.1 North America Oncology Immunotherapy Market Size by Country (2016-2027)
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe Oncology Immunotherapy Market Size by Country (2016-2027)
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific Oncology Immunotherapy Market Size by Region (2016-2027)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 Latin America
- 9.1 Latin America Oncology Immunotherapy Market Size by Country (2016-2027)
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Rest of Latin America
10 Middle East & Africa
- 10.1 Middle East & Africa Oncology Immunotherapy Market Size by Country (2016-2027)
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
- 10.5 Rest of Middle East & Africa
11 Oncology Immunotherapy Market Dynamics
- 11.1 Oncology Immunotherapy Industry Trends
- 11.2 Oncology Immunotherapy Market Drivers
- 11.3 Oncology Immunotherapy Market Challenges
- 11.4 Oncology Immunotherapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on Oncology Immunotherapy. Industry analysis & Market Report on Oncology Immunotherapy is a syndicated market report, published as Global Oncology Immunotherapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Oncology Immunotherapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
